SubscribeLogin
Inflation Reduction Act image

News from Inflation Reduction Act

Stay current with all the latest and breaking news about Inflation Reduction Act, compare headlines and perspectives between news sources on stories happening today. In total, 504 stories have been published about Inflation Reduction Act which Ground News has aggregated in the past 3 months.

Covered Most By

heatmap.news
heatmap.news
Unknown
EHN
EHN
Unknown
ecotopical.com
ecotopical.com
Unknown
Suggest a source
Suggest a source
Looking for a source we don't already have? Suggest one here.

Top Inflation Reduction Act News

Trump Proposes Fast-Track Permits for $1 Billion US Investments
Donald Trump · United States

Trump Proposes Fast-Track Permits for $1 Billion US Investments

36% Center coverage: 65 sources
President-elect Trump indicated on Tuesday that he’ll give expedited approvals to projects that invest at least $1 billion into the U.S. economy. See the Story
NOVONIX Offered Conditional Commitment for US$754 Million Loan from the U.S. Department of Energy for New Synthetic Graphite Manufacturing Plant in Tennessee - NOVONIX (NASDAQ:NVX), NOVONIX (OTC:NVNXF)
Auto

NOVONIX Offered Conditional Commitment for US$754 Million Loan from the U.S. Department of Energy for New Synthetic Graphite Manufacturing Plant in Tennessee - NOVONIX (NASDAQ:NVX), NOVONIX (OTC:NVNXF)

57% Right coverage: 7 sources
Figure 1 Site Rendering of NOVONIX's New Facility BRISBANE, Australia, Dec. 17, 2024 (GLOBE NEWSWIRE) -- NOVONIX Limited (NASDAQ:NVX, ASX: NVX)) ("NOVONIX" or "the Company"), a leading battery materials and technology company, announced today a conditional commitment to NOVONIX through one if its wholly-owned U.S.-based subsidiaries ("Borrower"), from the U.S. Department of Energy ("DOE") through the Loan Programs Office ("LPO") for a direct l…See the Story
Why Is Pfizer Stock Trading Higher On Tuesday? - Pfizer (NYSE:PFE)
Wall Street

Why Is Pfizer Stock Trading Higher On Tuesday? - Pfizer (NYSE:PFE)

83% Center coverage: 6 sources
On Tuesday, Pfizer Inc. (NYSE:PFE) released its full-year 2025 financial guidance, projecting revenues between $61.0 billion and $64.0 billion compared to a consensus of $63.28 billion. For 2025, Pfizer expects revenue from COVID-19 products to remain consistent with 2024, excluding approximately $1.2 billion in one-time Paxlovid revenue recognized in 2024. The guidance accounts for an estimated $1 billion net unfavorable revenue impact due to c…See the Story

Latest News Stories

You've scrolled to the bottom of the feed, there are no more stories.
Trending Topics
App Store IconPlay Store Icon
CompanyAboutHistoryMissionBlogTestimonialsGroup SubscriptionsSubscribeGiftFree TrialCareersAffiliates
HelpHelp CenterFAQContact UsFor Educators/LibrariesMedia Bias RatingsOwnership and Factuality RatingsReferral CodeNews SourcesTopics
ToolsAppBrowser ExtensionDaily NewsletterBlindspot Report NewsletterBurst Your Bubble NewsletterTimelines
DonatePrivacy PolicyManage CookiesTerms and Conditions
© 2024 Snapwise Inc
News
For You
Search
BlindspotLocal